Enhanced Lubricant Formulations with Improved Performance and Safety
Legal Citation
Summary of the Inventive Concept
This inventive concept presents a range of novel lubricant formulations that address the limitations of existing personal lubricants by incorporating hybrid-based lubricants, antimicrobial agents, and emulsifiers to enhance lubricity, stability, and comfort while reducing irritation.
Background and Problem Solved
The original patent disclosed lubricant compositions with antimicrobial agents, but these formulations had limitations in terms of lubricity, stability, and user comfort. The new inventive concept solves these problems by introducing hybrid-based lubricants, pH adjusters, and moisturizing agents to create a more efficient, safer, and comfortable lubricant.
Detailed Description of the Inventive Concept
The new lubricant formulations comprise a hybrid-based lubricant that combines water and silicone, an antimicrobial agent selected from hypochlorite, acid, or salts thereof, and an emulsifier. The emulsifier is present in an amount effective to improve lubricity and stability of the composition. Additionally, the formulations may include a moisturizing agent to enhance comfort and reduce irritation during use. The pH of the composition is adjusted to a range of about 4.5 to about 5.5 to ensure optimal performance.
Novelty and Inventive Step
The new claims introduce the concept of hybrid-based lubricants, pH adjusters, and moisturizing agents, which are not present in the original patent. These additions provide a significant improvement in lubricity, stability, and user comfort, making the new inventive concept novel and non-obvious.
Alternative Embodiments and Variations
Other embodiments of the inventive concept could include the use of different antimicrobial agents, such as quaternary ammonium compounds or essential oils. The hybrid-based lubricant could be modified to include different ratios of water and silicone or the addition of other lubricating agents. The emulsifier and moisturizing agent could be varied to optimize performance and comfort.
Potential Commercial Applications and Market
The enhanced lubricant formulations have significant commercial potential in the personal care industry, particularly in the market for intimate lubricants. The improved performance, safety, and comfort of these formulations could lead to increased market share and customer satisfaction.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0034 |
| A | A61 | A61K8/0216 |
| A | A61 | A61K8/20 |
| A | A61 | A61K8/24 |
| A | A61 | A61K8/25 |
| A | A61 | A61K8/891 |
| A | A61 | A61K33/20 |
| A | A61 | A61K47/02 |
| A | A61 | A61K47/34 |
| A | A61 | A61L31/14 |
| A | A61 | A61L31/16 |
| A | A61 | A61Q17/005 |
| A | A61 | A61Q19/00 |
| A | A61 | A61L2300/404 |
| A | A61 | A61L2400/10 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Personal care and medical lubricant compositions, specifically focusing on antimicrobial personal lubricants with silicone polymers and electrolyzed solutions, requiring expertise in chemical formulation, polymer chemistry, and medical product development
Person of Ordinary Skill (PHOSITA) Profile
A chemical engineer or formulation specialist with advanced degree in chemistry or chemical engineering, experienced in developing personal care products, familiar with silicone polymers, emulsification techniques, and antimicrobial agent interactions
Obviousness Rationale
A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's lubricant technology by introducing standard formulation techniques like hybrid lubricant systems, pH adjustment, and additional functional agents that are well-known in personal care product development. The core technological framework of the source patent provides clear motivation and technical foundation for these incremental improvements.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,674 |
|---|---|
| Title | Lubricant formulations |
| Assignee(s) | REOXCYN, LLC |